In multivariate analysis, YTHDF1 or YTHDF2 immunohistochemical expression was an independent favorable prognostic marker for overall survival in adenocarcinoma patients (hazard ratio (HR) = 0.418, p = 0.001 and HR = 0.449, p = 0.001, respectively; Table 2). This evidence concerns the gene YTHDF1 and adenocarcinoma.